securities class action

Kyndryl faces securities class action lawsuits after disclosing material control weaknesses and executive departures. Stock fell 55% to $10.59; lead plaintiff deadline set for April 13, 2026.

uniQure faces securities lawsuit after FDA rejected AMT-130 drug candidate data adequacy. Stock plunged 49% following disclosure. Lead plaintiff deadline April 13, 2026.

Rosen Law Firm urges $BSX investors to join securities lawsuit alleging false statements about U.S. Electrophysiology segment sustainability. Lead plaintiff deadline: May 4, 2026.

Aldeyra Therapeutics plummets 71% after FDA rejects lead dry eye drug. Securities litigation firm investigating potential investor claims following efficacy concerns.

Hagens Berman files securities class action against $CORT after FDA rejection of lead drug and federal court patent loss, alleging concealment of clinical data warnings.

Apollo Global Management faces securities lawsuit over undisclosed Jeffrey Epstein ties revealed in investigative reports. Stock plummeted 15%, erasing $12B in market cap.

$ODD crashes 49% after disclosing 30% revenue decline tied to advertising partner algorithm changes and customer acquisition cost surge.

Trip.com shares crashed 17% amid Chinese antitrust probe into AI pricing tool allegedly forcing hotel discounts. Securities lawsuit filed; company shut tool down.

Richtech Robotics faces securities lawsuit alleging it misled investors about a Microsoft partnership that was merely a free prototyping program, not a commercial collaboration. Stock fell 20% after Microsoft's denial.

Rosen Law Firm urges Camping World ($CWH) investors to join class action over alleged inventory misstatements. Lead plaintiff deadline: May 11, 2026.

Immutep's $IMMP stock crashed following discontinued Phase III trial for eftilagimod alfa. Rosen Law Firm launches investigation into potential securities claims and class action lawsuit.

Rosen Law Firm filed securities class action against $LU alleging false statements on internal controls and financials. Investors have until May 20, 2026 to claim lead plaintiff status.

Rosen Law Firm alerts $INO investors of April 7, 2026 deadline to join class action over alleged false statements regarding manufacturing and regulatory prospects.

Beyond Meat faces securities class action over alleged asset impairment misstatements; lead plaintiff deadline is March 24, 2026.

Rosen Law Firm notifies Corcept investors about securities lawsuit alleging misrepresentation of relacorilant clinical data and concealment of FDA concerns during October 2024-December 2025.

Rosen Law Firm filed securities class action against Concorde International Group ($CIGL) alleging fraudulent promotion schemes and insider share dumping. Affected investors must act before critical deadlines.

BlackRock TCP Capital faces securities lawsuit alleging NAV overstatement and misvaluation. Investors have until April 6, 2026, to join the class action.

Plug Power investors face April 3, 2026 deadline to join securities lawsuit alleging misleading DOE loan fund statements and hydrogen facility construction misrepresentations.

Rosen Law Firm recruits investors for securities class action against REGENXBIO over alleged RGX-111 gene therapy misstatements. Lead plaintiff deadline: April 14, 2026.

Rosen Law Firm files securities class action against Paysafe Limited, alleging false statements about business operations and financial performance. Investors must act before lead plaintiff deadline.